Annual EBIT
-$146.77 M
+$7.87 M+5.09%
December 31, 2023
Summary
- As of February 7, 2025, KYMR annual earnings before interest & taxes is -$146.77 million, with the most recent change of +$7.87 million (+5.09%) on December 31, 2023.
- During the last 3 years, KYMR annual EBIT has fallen by -$101.29 million (-222.72%).
- KYMR annual EBIT is now -584.19% below its all-time high of -$21.45 million, reached on December 31, 2018.
Performance
KYMR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$62.43 M
-$20.43 M-48.63%
September 30, 2024
Summary
- As of February 7, 2025, KYMR quarterly earnings before interest & taxes is -$62.43 million, with the most recent change of -$20.43 million (-48.63%) on September 30, 2024.
- Over the past year, KYMR quarterly EBIT has dropped by -$48.11 million (-336.06%).
- KYMR quarterly EBIT is now -684.46% below its all-time high of -$7.96 million, reached on September 30, 2020.
Performance
KYMR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$167.23 M
-$9.60 M-6.09%
September 30, 2024
Summary
- As of February 7, 2025, KYMR TTM earnings before interest & taxes is -$167.23 million, with the most recent change of -$9.60 million (-6.09%) on September 30, 2024.
- Over the past year, KYMR TTM EBIT has dropped by -$20.47 million (-13.94%).
- KYMR TTM EBIT is now -1364.89% below its all-time high of -$11.42 million, reached on September 30, 2019.
Performance
KYMR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KYMR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.1% | -336.1% | -13.9% |
| 3 y3 years | -222.7% | -336.1% | -13.9% |
| 5 y5 years | -584.2% | -336.1% | -13.9% |
KYMR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.7% | +5.1% | -336.1% | at low | -67.2% | +0.0% |
| 5 y | 5-year | -256.2% | +5.1% | -684.5% | at low | -630.3% | +0.0% |
| alltime | all time | -584.2% | +5.1% | -684.5% | at low | -1364.9% | +0.0% |
Kymera Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$62.43 M(+48.6%) | -$167.23 M(+6.1%) |
| Jun 2024 | - | -$42.00 M(-13.4%) | -$157.63 M(+2.1%) |
| Mar 2024 | - | -$48.49 M(+238.7%) | -$154.38 M(+5.2%) |
| Dec 2023 | -$146.77 M(-5.1%) | -$14.32 M(-72.9%) | -$146.77 M(-12.3%) |
| Sep 2023 | - | -$52.83 M(+36.3%) | -$167.26 M(+6.3%) |
| Jun 2023 | - | -$38.75 M(-5.2%) | -$157.40 M(-0.9%) |
| Mar 2023 | - | -$40.87 M(+17.4%) | -$158.86 M(+2.7%) |
| Dec 2022 | -$154.63 M(+54.6%) | -$34.81 M(-19.0%) | -$154.63 M(+0.6%) |
| Sep 2022 | - | -$42.97 M(+6.8%) | -$153.67 M(+10.4%) |
| Jun 2022 | - | -$40.22 M(+9.8%) | -$139.22 M(+12.6%) |
| Mar 2022 | - | -$36.64 M(+8.3%) | -$123.64 M(+23.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$100.04 M(+120.0%) | -$33.85 M(+18.7%) | -$100.04 M(+26.9%) |
| Sep 2021 | - | -$28.51 M(+15.8%) | -$78.85 M(+35.3%) |
| Jun 2021 | - | -$24.63 M(+88.7%) | -$58.30 M(+22.4%) |
| Mar 2021 | - | -$13.05 M(+3.1%) | -$47.63 M(+4.7%) |
| Dec 2020 | -$45.48 M(+10.4%) | -$12.66 M(+59.1%) | -$45.48 M(+2.7%) |
| Sep 2020 | - | -$7.96 M(-43.0%) | -$44.30 M(-7.2%) |
| Jun 2020 | - | -$13.96 M(+28.1%) | -$47.76 M(+41.3%) |
| Mar 2020 | - | -$10.90 M(-5.1%) | -$33.80 M(+47.6%) |
| Dec 2019 | -$41.20 M(+92.1%) | -$11.48 M(+0.6%) | -$22.90 M(+100.6%) |
| Sep 2019 | - | -$11.42 M | -$11.42 M |
| Dec 2018 | -$21.45 M | - | - |
FAQ
- What is Kymera Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Kymera Therapeutics?
- What is Kymera Therapeutics annual EBIT year-on-year change?
- What is Kymera Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly EBIT year-on-year change?
- What is Kymera Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Kymera Therapeutics?
- What is Kymera Therapeutics TTM EBIT year-on-year change?
What is Kymera Therapeutics annual earnings before interest & taxes?
The current annual EBIT of KYMR is -$146.77 M
What is the all time high annual EBIT for Kymera Therapeutics?
Kymera Therapeutics all-time high annual earnings before interest & taxes is -$21.45 M
What is Kymera Therapeutics annual EBIT year-on-year change?
Over the past year, KYMR annual earnings before interest & taxes has changed by +$7.87 M (+5.09%)
What is Kymera Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of KYMR is -$62.43 M
What is the all time high quarterly EBIT for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly earnings before interest & taxes is -$7.96 M
What is Kymera Therapeutics quarterly EBIT year-on-year change?
Over the past year, KYMR quarterly earnings before interest & taxes has changed by -$48.11 M (-336.06%)
What is Kymera Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of KYMR is -$167.23 M
What is the all time high TTM EBIT for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM earnings before interest & taxes is -$11.42 M
What is Kymera Therapeutics TTM EBIT year-on-year change?
Over the past year, KYMR TTM earnings before interest & taxes has changed by -$20.47 M (-13.94%)